Received Oct 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (HIBERIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
| MNQ | MENINGOCOCCAL CONJUGATE (MENACTRA) | SANOFI PASTEUR | UNK | UNK | — |
Allergic reaction; This non-serious case was reported by a other health professional via call center representative and described the occurrence of allergic reaction in a 64-year-old male patient who received Hib (Hiberix) for prophylaxis. Co-suspect products included MENINGOCOCCAL VACCINE A/C/Y/W CONJ (DIP TOX) (MENACTRA) for prophylaxis. On an unknown date, the patient received Hiberix and MENACTRA. On an unknown date, an unknown time after receiving Hiberix and MENACTRA, the patient experienced allergic reaction (Verbatim: Allergic reaction). The outcome of the allergic reaction was unknown. It was unknown if the reporter considered the allergic reaction to be related to Hiberix and MENACTRA. It was unknown if the company considered the allergic reaction to be related to Hiberix and MENACTRA. Additional Information: GSK receipt date: 09-SEP-2025 Other Health Professional reported that they want to order Bexsero for a patient who had an allergy to 2 vaccines in the past of Hiberix and Menactra and adjuvant (AS03) The reporter did not consent to follow-up.